Company intelligence / Profile preview

Abacus Group

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

The company does not develop its own drugs but provides parallel importation of prescription medicines across Europe and offers comparator sourcing for clinical trials. It enables better access to both branded small molecules and biologics in over thirty countries. Its pharma services division specializes in supporting biotech/pharma companies with market entry/commercialization in Europe—especially for rare/orphan disease products—and bespoke comparator sourcing throughout all phases of clinical development.

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Abacus Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abacus Group.

Explore the full profile